Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sido Muncul is Indonesia's leading manufacturer of traditional herbal medicines, known locally as Jamu, and a major player in the pharmaceutical and consumer health sectors. The company is world-renowned for its flagship product, Tolak Angin, a standardized herbal syrup used for cold relief and immune support. Operating from massive, GMP-certified facilities in Semarang, the company produces over 300 unique products including herbal supplements, energy drinks, and over-the-counter pharmaceuticals. Their business model emphasizes the modernization of traditional Indonesian remedies through rigorous scientific extraction and quality control processes. Sido Muncul serves a massive domestic market and exports to countries across Southeast Asia, Africa, and the Middle East. The company is publicly traded on the Indonesia Stock Exchange and maintains a vertically integrated structure encompassing extraction, production, and distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sido Muncul.